Abstract:Purpose of review Human kidney development and the mechanisms of many kidney diseases are incompletely understood partly due to the lack of appropriate models. Kidney organoids derived from human pluripotent stem cells (hPSCs) are a new and rapidly developing in-vitro system covering the window of early nephrogenesis and having the capacity for disease modelling. The application of global analytic tools such as RNA sequencing and proteomics is providing new and unexpected insights into kidney organoids with relevance for development and disease. In this review, we focus on the most significant advances in the field over the last 2 years. Recent findings There have been several protocol modifications for the differentiation of hPSCs into kidney organoids , including the additional step of implantation into mice. These changes have improved the vascularization and maturity of the major cell types in the organoids, increased the production scale, and reduced the cost and labour intensity of culturing organoids. Single-cell RNA sequencing and global proteomics of kidney organoids have provided important insights into the multiple cell populations, origin of cells, and regulatory relationships between genes. There has been an increase in research using patient-derived induced pluripotent stem cells (iPSCs), or combining gene editing with iPSC-derived kidney organoids as a novel disease-modelling platform for improving our understanding of disease mechanisms, drug testing and discovery, and the potential for personalized therapy. Finally, there has been progress in culturing hPSCs-derived kidney cells in microfluidic kidney-on-a-chip devices and this may provide a means of further improving the maturity of kidney organoids . Summary The review summarizes the latest progress on kidney organoids including differentiation protocols, analysis tools, and applications. Despite some limitations, hPSC-derived kidney organoids are authentic and practical models for investigating kidney development and disease and progressing understanding about tissue regeneration, drug screening , and disease modelling.

Research progress of pluripotent stem cells and kidney regeneration

Progress in non-renal derived adult stem cell therapy for kidney disease

Experimental Researches on Treatment of End-Stage Nephropathy with Stem Cells Transplantation

Human pluripotent stem cell-derived kidney organoids: Current progress and challenges

In VitroandIn VivoHepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases

Progress of native joint-resident stem cells/progenitor cells in cartilage regeneration

Composite materials combined with stem cells promote kidney repair and regeneration

The current status and outlook of stem cell transplantation

The Research Status of Induced Pluripotent Stem Cells

Progress in the Application of Immunosuppressants to Renal Transplant

Xenogeneic stem cell transplantation: Research progress and clinical prospects

Regenerative Medicine for the Kidney: Renotropic Factors, Renal Stem/Progenitor Cells, and Stem Cell Therapy

Recent Progress in Induced Cells

Advancements and challenges in stem cell transplantation for regenerative medicine

The myriad possibility of kidney organoids

Stem Cell Therapy and Immunological Rejection in Animal Models

Research Progress of Stem Cell Therapy for Liver Diseases

Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids

Enhancing regenerative medicine: the crucial role of stem cell therapy

Current status of human induced pluripotent stem cell donor origin and its epigenetic research

Several Key Issues on Hepatocyte/hepatic Stem Cell Transplantation